Navigation Links
Access MediQuip Moves Company Headquarters to Lake Mary, Florida
Date:11/9/2009

ies will capitalize on the outstanding business environment, infrastructure and healthcare resources that propelled our growth in the last several years," says Bill Elliott, Access MediQuip President and COO. "In addition to its pro-business climate, the Lake Mary area offers a talent pool with deep experience in specialty managed care that will facilitate our ability to attract the quality human resources we will need to achieve our vision."

Access MediQuip is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufacturers and providers to manage the acquisition, financing, delivery and reimbursement of implantable medical devices such as orthopedic and spinal implants. Founded in 1997, the company is now headquartered in Lake Mary, Florida. For more information, please visit www.accessmediquip.com.

SOURCE Access MediQuip, LLC


'/>"/>
SOURCE Access MediQuip, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, UnitedStatesDentalDevicesMarketAnalysis....com/p0158733/United-States-Dental-Devices-Market-...tatesDentalDevicesMarketAnalysisandForecaststo2015...ceforin-depthinformationanddatarelatingtotheUSdent...
(Date:11/25/2009)...HAM,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniu...hnologymarketintelligence,thenearly$3billionUSmark...owthoverthenextfiveyearsdespitetherecenteconomicsl...tfindsthatthismarketwillremainhighlydynamicoverthe...ddevicesinpreviouslyunderservedsegmentsofthetrauma...
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, IntranasalDrugDelivery-USMarketTrends&a...Intranasal-Drug-Delivery---US-Market-Trends--Analy...switnessinganexpansionoftherapeuticapplicationsfro...hedeliveryofsystemictherapeuticdrugs.Thefutureofth...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 1U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 2U of M part of 24185 million funded team tasked to improve global response to emerging pandemics 60411 3ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 1ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 2ESC events in Asia tackle management of diabetes and cardiovascular disease 60408 3GREENBioPharma Dec 2 3 2009 10591 1
...apentadol Efficacy and Tolerability for Acute Pain...ted that up to 30 percent of all people who have s...uch as nausea and vomiting. The use of opioid pain...isk factor for experiencing these side effects. Na... and can have an impact on a patient,s recovery. ,...
...l to be Held at 9:00 a.m. Eastern Time Today, May ...herapeutics Corporation (Nasdaq: UTHR ) announce...istration (FDA) has approved ADCIRCA(TM) (tadalafi...nded dose of 40 mg, as the first once-daily phosph...ent of pulmonary arterial hypertension (PAH). ADC...
Other Medicine Technology:New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4
(Date:11/25/2009)...ARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...sandsoftwareandCalgaryScientificInc.,aleadingprovi...ebversionofAegis(TM)Breast4DAdvancedVisualizations...ulyzero-footprintWebclientbasedmedicalimagingoffer...ormallowsforzero-footprintaccess-requiringnosoftwa...
(Date:11/25/2009)...d.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJanet...ationandResearch,titled"ADifficultBalance-PainMana...09issueofTheNewEnglandJournalofMedicine. ,, (Lo...DALOGO ) ,, Inthearticle,WoodcockdiscussesFDAef...forthosewhoneeditandmanagingtherisksposedbyvarious...
(Date:11/25/2009)...lEndorsements,Business,andPressJoinEfforttoEducate.../--Onceagain,theNationalBipolarFoundationandtheMed...r"Safe,tilStable"program,whichisnowbeingwidelyacce...er.Today,theNationalBipolarFoundationreceivedaproc...fromtheLt.GovernorofLouisianaMitchLandrieu.TheNati...
(Date:11/25/2009)...very that grew out of a collaboration between UCLA...hope to the nearly 10 million Americans who suffer...own as hardening of the arteries, peripheral arter...em in which narrowed arteries reduce blood flow to... for vascular disease, heart attack and stroke, an...
(Date:11/25/2009)...d to fight rheumatoid arthritis, could help newly ...NESDAY, Nov. 25 (HealthDay News) -- A drug commonl...oid arthritis now also shows some promise in helpi..., The drug, rituximab (Rituxan), helped patient...hough the disease had destroyed some of their panc...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... MedicareSupplementPlans.co...nce agencies specializing in Medicare supplement i... cap on Medicare services and provide seniors with...ns.com: Legislation designed to remove Medicare&rs...
..., , , SCHAUMBURG, Ill., April 24 World Veterina...elationship between veterinarians and livestock fa...and Livestock Farmers: a winning , partnershi...cer of the American Veterinary Medical Association...
...SAN DIEGO - Researchers from the Children,s Cancer...n Cancer Center have discovered a new drug combina...uroblastoma, a childhood cancer. The study was pre...or, vandetanib, with 13-cis-retinoic acid (CRA), a...
...ditional impairment charge anticipated in the four...orium Group, Inc. (Nasdaq: ENCO ), a full servi...RO) that provides design, development, and managem... 2009 it received a letter from Nasdaq stating tha...
...mpany will showcase technologies for brachytherapy...c(TM) radiotherapy, and stereotactic body radiothe...an Medical Systems (NYSE: VAR ) will showcase th...n Chicago from April 25-30. , , "Varian offers st...
...ey finds that psychological needs are going unmet,...People with heart failure, and those who care for ...cal needs, a new study finds. , "Heart failure pat...lth Sciences Center, who was to present the study ...
Other Medicine News:Health News:MedicareSupplementPlans.com Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients 2Health News:AVMA Celebrates World Veterinary Day 2Health News:Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation 2Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 2Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 3Health News:Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing 4Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 2Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 3Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 4Health News:Reduce Suffering, Urge Heart Failure Patients and Caregivers 2Health News:Reduce Suffering, Urge Heart Failure Patients and Caregivers 3
CONCERT® Spine VR Bone Cement
...urgeon describes samples taken with,the new Comp...ns a,cleaner cut and larger sample for histopath...s optimized vacuum and cutting edge., Unique "O ...cuum,in the needle so that suction concentrates ...
CVC 9005 Hematocrit Calibration Verification Control (for use with the IRMA TRUpoint Blood Analysis System)
QC 233 CO-Oximeter Control
Medicine Products: